SGLT2 inhibitors as the bedrock of therapy for heart failure.
washington; spokane; pmrc; Diabetes Mellitus, Type 2; Heart Failure; Humans; Hypoglycemic Agents; Sodium-Glucose Transporter 2 Inhibitors
Kidney & Diabetes
Tuttle, Katherine and Rangaswami, Janani, "SGLT2 inhibitors as the bedrock of therapy for heart failure." (2022). Articles, Abstracts, and Reports. 6449.